Eli Lilly misses 2024 revenue expectations, stock dips 7%news2025-01-14T20:38:09+00:00January 14th, 2025|Endpoints News|
FTC goes after pharma middlemen’s price hikes on ‘specialty’ drugsnews2025-01-14T16:15:58+00:00January 14th, 2025|Endpoints News|
Can the Pfizer machine fight back against an activist investor?news2025-01-14T16:08:49+00:00January 14th, 2025|Endpoints News|
#JPM25: Day 2 at the JP Morgan Healthcare Conferencenews2025-01-14T12:00:48+00:00January 14th, 2025|Endpoints News|
Gottlieb says RFK Jr. as HHS secretary could bring ‘tragic’ outbreaksnews2025-01-13T20:09:29+00:00January 13th, 2025|Endpoints News|
Moderna lowers 2025 revenue estimate, announces more cost cutsnews2025-01-13T19:43:33+00:00January 13th, 2025|Endpoints News|
Federal Circuit upholds Novartis patent for heart drug Entrestonews2025-01-13T19:09:46+00:00January 13th, 2025|Endpoints News|
AbbVie partners with Simcere Pharma unit to develop myeloma drugnews2025-01-13T16:46:11+00:00January 13th, 2025|Endpoints News|
#JPM25: Day 1 at the JP Morgan Healthcare Conferencenews2025-01-13T12:00:19+00:00January 13th, 2025|Endpoints News|
Breaking: J&J looks at potential bid for Intra-Cellular — reportnews2025-01-12T22:55:47+00:00January 12th, 2025|Endpoints News|
